Use of Oral Fluoroquinolones in Canada: Drug Utilization Study Update

Details

Files

Project Status:

Complete

Project Line:

Health Technology Review

Project Sub Line:

Technology Review

Project Number:

HC0073-000

Expected finish date:

August 27, 2024

Health Canada conducted various risk assessments of systemic fluoroquinolones, which enabled them to take regulatory measures in 2017, including issuing a Dear Health Care Professional Letter, updating their labels, and amending their indications to reflect their risk-benefit profile.

The main objective of the query is to assess the impact of the risk-minimization measures applied in 2017 by comparing the current trends of fluoroquinolone use to those from a previous drug utilization study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES).